BioCardia Inc (BCDA)
2.015
-0.34
(-14.26%)
USD |
NASDAQ |
Nov 14, 16:00
2.06
+0.04
(+2.23%)
After-Hours: 05:38
BioCardia Cash and Short Term Investments (Quarterly): 1.421M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.421M |
| March 31, 2024 | 0.949M |
| December 31, 2023 | 1.103M |
| September 30, 2023 | 1.835M |
| June 30, 2023 | 4.305M |
| March 31, 2023 | 4.857M |
| December 31, 2022 | 7.363M |
| September 30, 2022 | 6.667M |
| June 30, 2022 | 8.614M |
| March 31, 2022 | 9.93M |
| December 31, 2021 | 12.87M |
| September 30, 2021 | 15.89M |
| June 30, 2021 | 18.54M |
| March 31, 2021 | 21.50M |
| December 31, 2020 | 21.41M |
| September 30, 2020 | 7.392M |
| June 30, 2020 | 11.09M |
| March 31, 2020 | 2.587M |
| December 31, 2019 | 5.585M |
| September 30, 2019 | 8.91M |
| June 30, 2019 | 0.517M |
| March 31, 2019 | 2.838M |
| December 31, 2018 | 5.358M |
| September 30, 2018 | 4.82M |
| June 30, 2018 | 6.834M |
| Date | Value |
|---|---|
| March 31, 2018 | 9.653M |
| December 31, 2017 | 12.69M |
| September 30, 2017 | 15.12M |
| June 30, 2017 | 16.90M |
| March 31, 2017 | 19.03M |
| December 31, 2016 | 21.35M |
| September 30, 2016 | 19.44M |
| June 30, 2016 | 13.87M |
| March 31, 2016 | 13.92M |
| December 31, 2015 | 13.84M |
| September 30, 2015 | 13.73M |
| June 30, 2015 | 13.69M |
| March 31, 2015 | 13.60M |
| December 31, 2014 | 13.51M |
| September 30, 2014 | 13.46M |
| June 30, 2014 | 13.40M |
| March 31, 2014 | 13.32M |
| December 31, 2013 | 13.30M |
| September 30, 2013 | 13.26M |
| June 30, 2013 | 13.27M |
| March 31, 2013 | 13.25M |
| December 31, 2012 | 13.27M |
| September 30, 2012 | 12.82M |
| June 30, 2012 | 12.88M |
| March 31, 2012 | 12.65M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.949M
Minimum
Mar 2024
21.50M
Maximum
Mar 2021
8.627M
Average
7.363M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 2.780B |
| The Cooper Companies Inc | 109.70M |
| Theriva Biologics Inc | 16.59M |
| Zevra Therapeutics Inc | 49.26M |
| Instil Bio Inc | 148.61M |